Market Analysis and Insights: Global and China Non-opioid Pain Patches Market
This report focuses on global and China Non-opioid Pain Patches market.
In 2020, the global Non-opioid Pain Patches market size was US$ 631.4 million and it is expected to reach US$ 779.5 million by the end of 2027, with a CAGR of 2.6% during 2021-2027. In China the Non-opioid Pain Patches market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Non-opioid Pain Patches Scope and Market Size
Non-opioid Pain Patches market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Non-opioid Pain Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Non-opioid Pain Patches market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others

Segment by Application
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International